Skip to content
ESSA Pharma
  • Our Company
    • About Us
    • Executive Team
    • Board of Directors
    • Scientific Advisors
    • Careers
  • Pipeline
    • Pipeline
    • Expanded Access Policy
    • Androgen Receptor
    • Aniten Compounds
    • Publications
  • News
  • Investors
    • Investor Info
    • Corporate Governance
    • Events & Presentations
    • Financial Information
    • Stock Information
    • Analyst Coverage
    • Investor Contact
    • Publications
    • SEC Regulatory Filings
  • Contact
ESSA PHARMA, INC. HAS BEGUN DEVELOPMENT OF A SECOND GENERATION ANITEN COMPOUND FOR THE TREATMENT OF HORMONE-DRIVEN CANCER

News

News Archives

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
Date Title
April 14, 2021

ESSA Pharma to Present at the Bloom Burton & Co. Healthcare Investor Conference

April 10, 2021

ESSA Pharma Presents Preclinical Data Supporting the Therapeutic Potential of EPI-7386 at the 2021 American Association of Cancer Research

March 26, 2021

ESSA Announces Change to its Board of Directors

March 4, 2021

ESSA Pharma Announces Exercise of Option in Connection with Recently Completed $130 Million Financing

February 25, 2021

ESSA Pharma Inc. Reports Results of Annual General & Special Meeting of Shareholders

February 25, 2021

ESSA Pharma to Present at Upcoming March Investor Conferences

February 25, 2021

ESSA Pharma Announces Clinical Collaboration with Astellas to Evaluate the Combination of EPI-7386 and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer

February 22, 2021

Essa Pharma Announces Closing of $130 Million Public Offering of Common Stock

February 17, 2021

ESSA Pharma Announces Pricing of Public Offering of Common Shares

February 16, 2021

ESSA Pharma Announces Proposed Public Offering of Common Shares

  • 1
  • 2
  • »
  • Home
  • Our Company
  • Executive Team
  • Board of Directors
  • Scientific Advisors
  • Careers
  • Pipeline
  • Expanded Access Policy
  • Androgen Receptor
  • Aniten Compounds
  • Publications
  • News
  • Press Releases
  • Investors
  • Corporate Governance
  • Events & Presentations
  • Financial Information
  • Stock Information
  • Analyst Coverage
  • Investor Contact
  • Contact
  • Locations & Inquiries
© ESSA Pharma, Inc. 2020. All rights reserved. Privacy Policy | Terms & Conditions | Code of Conduct